Senior insider sale
Chief Executive Officer at LEGEND BIOTECH CORP — senior position signals high conviction
$1.54M
69.31K shares
What this filing means
HUANG YING plans to sell 69.31K shares of LEGEND BIOTECH CORP valued at approximately $1.54M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/26/2026ACC: 0001959173-26-002641
DirectorOfficer· Chief Executive Officer
Since Mar 2026
69.31K
Shares to sell
$1.54M
Approx. market value
4.97K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/20/2026
4.97KTotal acquired4.97K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/20/2026 | Restricted Stock Vesting Compensation | 4.97K | — |
| Total | 4.97K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
64.34K
Market value
$1.45M
12/26/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.97K
Market value
$87.1K
3/26/2026
Total
Units
69.31K
Value
$1.54M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/26/2025 | 64.34K | $1.45M | — | Completed |
| Planned — Approximate Date | ||||
3/26/2026 | 4.97K | $87.1K | NASDAQ | Planned |
| Total | 69.31K | $1.54M | ||